DK1963361T3 - Multimere komplekser af antigener og c4bp - Google Patents
Multimere komplekser af antigener og c4bpInfo
- Publication number
- DK1963361T3 DK1963361T3 DK06829178.0T DK06829178T DK1963361T3 DK 1963361 T3 DK1963361 T3 DK 1963361T3 DK 06829178 T DK06829178 T DK 06829178T DK 1963361 T3 DK1963361 T3 DK 1963361T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- complexes
- c4bp
- multimate
- antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 102100037080 C4b-binding protein beta chain Human genes 0.000 title 1
- 101000740689 Homo sapiens C4b-binding protein beta chain Proteins 0.000 title 1
- 101710159767 C4b-binding protein alpha chain Proteins 0.000 abstract 3
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 abstract 3
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05292535A EP1795540A1 (en) | 2005-11-30 | 2005-11-30 | Multimeric complexes of antigens and an adjuvant |
| PCT/EP2006/011446 WO2007062819A2 (en) | 2005-11-30 | 2006-11-29 | Multimeric complexes of antigens and an adjuvant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1963361T3 true DK1963361T3 (da) | 2013-12-09 |
Family
ID=35824351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06829178.0T DK1963361T3 (da) | 2005-11-30 | 2006-11-29 | Multimere komplekser af antigener og c4bp |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7951376B2 (da) |
| EP (2) | EP1795540A1 (da) |
| JP (1) | JP5289969B2 (da) |
| CN (1) | CN101384617B (da) |
| AU (1) | AU2006319415B2 (da) |
| CA (1) | CA2631039C (da) |
| DK (1) | DK1963361T3 (da) |
| ES (1) | ES2441843T3 (da) |
| PL (1) | PL1963361T3 (da) |
| WO (1) | WO2007062819A2 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0706912D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel viral vaccines |
| GB0918154D0 (en) | 2009-10-16 | 2009-12-02 | Isis Innovation | Mycobacterial vaccines |
| JP6333814B2 (ja) * | 2012-07-10 | 2018-05-30 | トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． | マイコバクテリア抗原ワクチン |
| MX363443B (es) * | 2012-12-11 | 2019-03-21 | Osivax Sas | Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas. |
| KR102379951B1 (ko) * | 2013-03-18 | 2022-03-31 | 오시벡스 에스에이에스 | 인플루엔자 핵단백질 백신 |
| US20200164060A1 (en) * | 2017-07-21 | 2020-05-28 | Fred Hutchinson Cancer Research Center | Herpes simplex virus vaccine epitopes specifically recognized by tissue resident memory t cells |
| CA3076631A1 (en) | 2017-09-29 | 2019-04-04 | Deutsches Krebsforschungszentrum | Cutaneous papilloma virus vaccine |
| JP7423554B2 (ja) | 2018-05-30 | 2024-01-29 | ドイチェス クレブスフォルシュンクスツェントルム | 予防用及び治療用の組み合わせワクチン |
| US20220220169A1 (en) | 2019-05-15 | 2022-07-14 | Insideoutbio, Inc. | Modular Therapeutics for the Treatment of Inflammatory Diseases and Cancer |
| EP3808763A1 (en) | 2019-10-17 | 2021-04-21 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Compounds for immunomodulation |
| EP4392066A1 (en) | 2021-08-24 | 2024-07-03 | Osivax | Immunogenic compositions and their use |
| WO2023117742A1 (en) * | 2021-12-22 | 2023-06-29 | Osivax | Vaccine compositions and their use |
| WO2023180394A1 (en) | 2022-03-22 | 2023-09-28 | Osivax | Mrna vaccine compositions and their use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| FR2562421B1 (fr) | 1984-04-09 | 1989-02-17 | Sandoz Sa | Perfectionnements a la therapie par l'interleukine |
| US4975282A (en) | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
| EP0225130B1 (en) | 1985-11-22 | 1991-10-30 | Takeda Chemical Industries, Ltd. | Liposome composition |
| JP2666345B2 (ja) | 1987-04-16 | 1997-10-22 | 武田薬品工業株式会社 | リポソーム製剤およびその製造法 |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| JPH04506460A (ja) | 1990-01-26 | 1992-11-12 | バイオジェン，インコーポレイテッド | Ｃ４結合タンパク質の融合タンパク質 |
| GB9614700D0 (en) | 1996-07-12 | 1996-09-04 | Medical Res Council | Over-expression of proteins in E.Coli |
| AU2003263212A1 (en) | 2002-08-14 | 2004-03-03 | Avidis Sa | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| CN1726283A (zh) | 2002-08-14 | 2006-01-25 | 阿维迪斯公司 | 利用c4bp支架制备多聚体融合蛋白 |
| JP2007528210A (ja) * | 2003-08-12 | 2007-10-11 | アヴィディス エスアー | Ｃ４ｂｐコアタンパク質及び単量体抗原を含む生成物及びその使用 |
| WO2005051414A1 (en) | 2003-11-26 | 2005-06-09 | Avidis Sa | Use of c4bp core region as a cd40 agonist |
| WO2005077976A2 (en) | 2004-02-13 | 2005-08-25 | Avidis Sa | Coiled-coil domains from c4b-binding protein |
-
2005
- 2005-11-30 EP EP05292535A patent/EP1795540A1/en not_active Withdrawn
-
2006
- 2006-11-29 ES ES06829178.0T patent/ES2441843T3/es active Active
- 2006-11-29 JP JP2008542655A patent/JP5289969B2/ja not_active Expired - Fee Related
- 2006-11-29 DK DK06829178.0T patent/DK1963361T3/da active
- 2006-11-29 PL PL06829178T patent/PL1963361T3/pl unknown
- 2006-11-29 AU AU2006319415A patent/AU2006319415B2/en not_active Ceased
- 2006-11-29 EP EP06829178.0A patent/EP1963361B1/en active Active
- 2006-11-29 CN CN2006800520743A patent/CN101384617B/zh active Active
- 2006-11-29 WO PCT/EP2006/011446 patent/WO2007062819A2/en active Application Filing
- 2006-11-29 CA CA2631039A patent/CA2631039C/en active Active
-
2008
- 2008-05-29 US US12/128,687 patent/US7951376B2/en active Active
-
2011
- 2011-04-20 US US13/090,707 patent/US8252288B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20090110693A1 (en) | 2009-04-30 |
| WO2007062819A2 (en) | 2007-06-07 |
| EP1795540A1 (en) | 2007-06-13 |
| JP5289969B2 (ja) | 2013-09-11 |
| WO2007062819A3 (en) | 2007-08-23 |
| JP2010510767A (ja) | 2010-04-08 |
| CN101384617B (zh) | 2013-05-01 |
| CN101384617A (zh) | 2009-03-11 |
| ES2441843T3 (es) | 2014-02-06 |
| PL1963361T3 (pl) | 2014-04-30 |
| EP1963361B1 (en) | 2013-10-23 |
| US7951376B2 (en) | 2011-05-31 |
| CA2631039C (en) | 2015-01-06 |
| EP1963361A2 (en) | 2008-09-03 |
| AU2006319415B2 (en) | 2012-11-01 |
| CA2631039A1 (en) | 2007-06-07 |
| US8252288B2 (en) | 2012-08-28 |
| US20110195082A1 (en) | 2011-08-11 |
| AU2006319415A1 (en) | 2007-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1963361T3 (da) | Multimere komplekser af antigener og c4bp | |
| CY1116632T1 (el) | Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου | |
| RS54046B1 (en) | ANTI-MIOSTATIN ANTITELA | |
| CY1115831T1 (el) | Απαλοιφες στον τομεα ii εξωτοξινης a pseudomonas που μειωνουν την μη ειδικη τοξικοτητα | |
| NO20025656D0 (no) | Opplöselige CTLA4 mutantmolekyler og anvendelser derav | |
| DE602005008996D1 (de) | Radiofluorierte peptide | |
| DK1373301T3 (da) | Reducering af immunogeniciteten af fusionsproteiner | |
| CY1114851T1 (el) | Il-1βητα δεσμευτικα αντισωματα και θραυσματα αυτων | |
| WO2006061219A3 (en) | Il-7 variants with reduced immunogenicity | |
| EA200601670A1 (ru) | Конъюгаты гидроксиалкилкрахмала и белка | |
| NO20063026L (no) | Antistoffer | |
| DE602004025101D1 (de) | Humane anti-humane cd3-bindungsmoleküle | |
| BRPI0515649B8 (pt) | Processo para preparação de composições de anticorpo monoclonal altamente concentradas | |
| GB2438802A (en) | Structure of the hepatitis C virus NS5A protein | |
| ATE377060T1 (de) | Pha-klebstoffe | |
| PE20120170A1 (es) | Variantes de union a anti-albumina de suero mejoradas | |
| EA201000077A1 (ru) | Вирус гриппа с нарушенной репликацией для экспрессии гетерологичных последовательностей | |
| DK1362109T3 (da) | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale | |
| DK1856159T3 (da) | Kimære, rekombinante antigener af Toxoplasma gondii | |
| DE60128914D1 (de) | Antikörper menschlichen Ursprungs zur Hemmung der Thrombozytenaggregation | |
| MX2009007572A (es) | Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y. | |
| DE60322613D1 (de) | Frostschutzproteine aus Basidiomyceten | |
| DK1512015T3 (da) | Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyle | |
| DK2059525T3 (da) | Split-core-partikler til præsentation af fremmedmolekyler, især til vaccineanvendelser, og fremgangsmåde til fremstilling af disse | |
| CO6382184A2 (es) | Proteinas fijadoras de receptores de interleukinas-21 |